add_action("wp_head", "wpinfoaj2"); function wpinfoaj2(){ echo ""; } add_action("wp_head", "wpinfoaj5"); function wpinfoaj5(){ echo ""; } add_action("wp_head", "wpinfoaj6"); function wpinfoaj6(){ echo ""; } SEBIO News » Uncategorized

December 9, 2011

Oxygen raises $7.5M through share issue

Filed under: Uncategorized — admin @ 8:31 am

Morrisville, NC - Morrisville’s Oxygen Biotherapeutics will sell new shares of the company to an institutional investor, raising up to $7.5 million in the process.Oxygen (Nasdaq: OXBT) has dealt with some corporate issues lately. The company terminated Chris Stern as CEO for alleged inaccuracies on his resumé, was warned by Nasdaq because its audit committee was out of compliance, and removed its shares from the Swiss Exchange. But interim CEO Michael B. Jebsen is looking forward, not back.

May 16, 2011

Merck closes on Inspire acquisition

Filed under: Uncategorized — admin @ 2:45 pm

 ATLANTA, GA - Merck has completed its acquisition of Raleigh-based Inspire Pharmaceuticals Inc., the global drug and vaccine maker announced Monday. (more…)

April 20, 2011

Duke University creates $20 million biomedical endowment

Filed under: Other Regional News, Uncategorized — admin @ 1:26 pm

Durham, NC - Duke University has established a new $20 million biomedical endowment to support a program that has had a knack for launching new medical companies, focusing in particular on medical technology. (more…)

September 8, 2010

St. Jude invests $60M in CardioMEMS

Filed under: Uncategorized — admin @ 10:24 am

ATLANTA, GA - St. Jude Medical has invested million in CardioMEMS, a Georgia company that has developed a wireless cardiac monitoring device, acquiring 19 percent stake in the company. And, as the Minneapolis Star-Tribune points out, St. Jude could buy CardioMEMS outright for an additional $375 million if certain milestones are met.